TA
Tim Anderson BofA Securities Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
37
Avg Return
Past Year
Past Year
8.8%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
30.8%
Neutral
43.6%
Negative
25.6%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Mega Cap
Over $200B
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Underperform
Maintained
| $627 |
20%
downside
| 3 | -2.9% |
0
%
| 29 Oct ‘25 29 days ago |
|
|
|
Neutral
Maintained
| $204 |
2%
downside
| 8 | – |
–
| 15 Oct ‘25 1 month ago |
|
|
|
Neutral
Maintained
| $30 |
17%
upside
| 3 | – |
–
| 3 Oct ‘25 1 month ago |
|
|
|
Underperform
Maintained
| $272 |
21%
downside
| 5 | -5.2% |
0
%
| 26 Sep ‘25 2 months ago |
|
|
|
Buy
Maintained
| $87 |
24%
upside
| 1 | +86% |
0
%
| 28 Aug ‘25 3 months ago |
|
|
|
Buy
Maintained
| $50 | – | 2 | +60% |
0
%
| 28 Aug ‘25 3 months ago |
|
|
|
Buy
Maintained
| $25 |
159%
upside
| 3 | -1.3% |
0
%
| 28 Aug ‘25 3 months ago |
|
|
|
Neutral
Maintained
| $204 |
10%
downside
| 4 | – |
–
| 28 Apr ‘25 7 months ago |
|
|
|
Buy
Maintained
| $126 |
1%
downside
| 3 | +12% |
0
%
| 5 Mar ‘25 8 months ago |
|
|
|
Underperform
Maintained
| $34 |
36%
upside
| 2 | +26% |
0
%
| 11 Feb ‘25 9 months ago |
|
|
|
Buy
Maintained
| $112 |
7%
upside
| 2 | +1.4% |
0
%
| 5 Feb ‘25 9 months ago |
|
|
|
Neutral
Reinstated
| $63 |
28%
upside
| 1 | – |
–
| 10 Dec ‘24 11 months ago |
|
|
|
Neutral
Reinstated
| $178 |
2%
downside
| 1 | – |
–
| 10 Dec ‘24 11 months ago |
|
|
|
Buy
Reinstated
| $997 |
10%
downside
| 1 | +37% |
0
%
| 10 Dec ‘24 11 months ago |
|